Paradigm Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-17,600
| Closed | -$465K | – | 525 |
|
|
2017
Q2 | $465K | Sell |
17,600
-18,100
| -51% | -$478K | 0.09% | 238 |
|
|
2017
Q1 | $743K | Buy |
+35,700
| New | +$743K | 0.14% | 168 |
|
|
2016
Q2 | – | Sell |
-3,000
| Closed | -$52.4K | – | 835 |
|
|
2016
Q1 | $52.4K | Hold |
3,000
| – | – | 0.01% | 576 |
|
|
2015
Q4 | $102K | Buy |
+3,000
| New | +$102K | 0.02% | 493 |
|
|
2014
Q3 | – | Sell |
-1,900
| Closed | -$64.6K | – | 876 |
|
|
2014
Q2 | $64.6K | Buy |
+1,900
| New | +$64.6K | 0.01% | 690 |
|